1
STAGNI MARCELLO: Use of enhancers, possibly associated to riboflavin, as well as corresponding ophthalmic compositions for corneal cross-linking in the treatment of the keratoconus or of other corneal ectasic disorders. SOOFT ITALIA, Sarpi Maurizio, March 4, 2010: WO/2010/023705 (9 worldwide citation)

Described herein is the use of enhancers with possibly riboflavin, as well as the corresponding compositions for the treatment of keratoconus or other ectasic corneal disorders by means of the method of corneal cross-linking.


2

3
Marcello STAGNI, Edoardo STAGNI, Massimo FILIPPELLO, Giovanni CAVALLO, Eugenio SODO: Use of enhancers, possibly associated to riboflavin, as well as corresponding ophthalmic compositions for corneal cross-linking in the treatment of the keratoconus or of other corneal ectasic disorders. Sooft Italia, June 23, 2011: US20110152219-A1

The use of enhancers with possibly riboflavin, as well as the corresponding compositions for the treatment of keratoconus or other ectasic corneal disorders by the method of corneal cross-linking.


4
Stagni Marcello, Stagni Edoardo, Filippello Massimo, Cavallo Giovanni, Sodo Eugenio: Use of enhancers, possibly associated to riboflavin, as well as corresponding ophthalmic compositions for corneal cross-linking in the treatment of the keratoconus or of other corneal ectasic disorders. Sooft Italia, gu jinwei peng kunpeng, August 24, 2011: CN200980138188

Described herein is the use of enhancers with possibly riboflavin, as well as the corresponding compositions for the treatment of keratoconus or other ectasic corneal disorders by means of the method of corneal cross-linking.



Click the thumbnails below to visualize the patent trend.